Atriva Therapeutics Gmbh

Calculating rank

USPTO Granted Patents = 6

% Expired Patents = 33.3

EPO Patents = 7

Forward Citations = 4

Loading Chart...

4 inventors (with patents filed for the assignee):

Stephan Ludwig (4 out of 7 patents)

Oliver Planz (4 out of 5 patents)

Christina Ehrhardt (2 out of 3 patents)

4. Stephan Pleschka (1 out of 2 patents)

5. Michael Schindler (3 patents)

6. Julia Koch-heier (0 patent)

7. Helen Elisa Hoffmann (0 patent)

8. Sascha Rohn (0 patent)

9. Peer Riehle (0 patent)

10. Carmen Hartmayer (0 patent)

6 patents: Sort by Forward Citations

1. 12661331 - MEK inhibitors for the treatment of hantavirus infections (2026-06-23),

2. 12350244 - MEK-inhibitor for the treatment of viral and bacterial infections (2025-07-08),

3. 11903917 - MEK-inhibitor for the treatment of viral and bacterial infections (2024-02-20),

4. 11135263 - Novel-anti-infective strategy against influenza virus andcoinfections (2021-10-05),

5. 10456440 - Anti-infective strategy against influenza virus andcoinfections (2019-10-29),

6. 9566281 - MEK inhibitors in the treatment of virus diseases (2017-02-14),

Company Overview

Atriva Therapeutics is a biopharmaceutical company focusing on the development of small molecule antiviral treatments. Leveraging their innovative drug discovery platform, they aim to combat viral infections and improve patient outcomes. With a strong pipeline of novel antiviral compounds, Atriva Therapeutics is dedicated to addressing unmet medical needs in infectious diseases.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

6 Patents

#21 in Tübingen

#5,406 in Germany

Tübingen, Germany

Atriva Therapeutics Gmbh

Forward Citations = 4

4 inventors:

Stephan Ludwig (4 out of 7 patents)

Oliver Planz (4 out of 5 patents)

Christina Ehrhardt (2 out of 3 patents)

4. Stephan Pleschka (1 out of 2 patents)

5. Michael Schindler (3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Atriva Therapeutics Gmbh. Retrieved from https://idiyas.com/company/atriva-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

7 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]